Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Prevent influenza virus infections systematically

29.01.2013
ViroSign - an interdisciplinary BMBF funded network

Viral epidemics and pandemics remain a constant threat for human population. This impact was particularly demonstrated by the recent transmission and explosive worldwide spread of a swine origin influenza virus among humans and the ongoing highly lethal infections with avian subtype strains.


Influenza viruses close to a host cell

Influenza virus infections are a major cause for respiratory disease, which affect all age groups and can occur repeatedly in any particular individual.

The newly established research network “ViroSign – Systems Virology of Influenza – Molecular Signature of permissive Virus Infection” is an interdisciplinary project that combines different aspects of systems biology ranging from the global system-wide analysis of cellular proteins to high-resolution microscopy of single viruses and mathematical modeling.

The aim is to unravel the interaction network of each viral component as well as the signature of all cellular proteins (proteome) produced by the host-cell as a response to the pathogen. Experiments and theory will be directed towards the identification of cellular interactors and viral proteins responsible for a specific host cell response. Bioinformatics will build upon these results and integrate previous data on studies as the identification of host cell factors required for virus replication. “This identification will allow the construction of a systemic model of influenza virus host interaction and will be useful for making predictions for the specific design and application of drugs and inhibitors to prevent infection”, explains Andreas Herrmann, Professor at the Department of Molecular Biophysics at Humboldt-Universität zu Berlin and ViroSign Co-ordinator.

The project is funded with 1,94 Mill. € by the Federal Ministry of Education and Research in the frame of the program e:Bio. Teams with complementary expertise of different institution in the Berlin region are involved: Integrative Research Institute (IRI) for the Life Sciences at Humboldt-Universität zu Berlin (Prof. Dr. Dr. h.c. Edda Klipp, Prof. Dr. Andreas Herrmann (co-ordinator)), Max-Planck-Institute for Infection Biology (Prof. Dr. Thomas Meyer), Robert-Koch-Institute Berlin (PD Dr. Thorsten Wolff) and Max-Delbrück-Center for Molecular Medicine (Prof. Dr. Matthias Selbach).

Contact
Prof. Dr. Andreas Herrmann
Humboldt-Universität zu Berlin
Department of Biology
Phone: +49 30 2093-8830
Andreas.Herrmann@rz.hu-berlin.de

Constanze Haase | idw
Further information:
http://www.hu-berlin.de

More articles from Life Sciences:

nachricht The interactome of infected neural cells reveals new therapeutic targets for Zika
23.01.2017 | D'Or Institute for Research and Education

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New technology for mass-production of complex molded composite components

23.01.2017 | Process Engineering

Quantum optical sensor for the first time tested in space – with a laser system from Berlin

23.01.2017 | Physics and Astronomy

The interactome of infected neural cells reveals new therapeutic targets for Zika

23.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>